November 28, 2022
Loading...
You are here:  Home  >  'Arcutis Biotherapeutics'
Latest

Arcutis reports Q3 loss, but first product revenue

By   /  Tuesday, November 8th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Tri-County Public Companies, Ventura County  /  No Comments

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Arcutis to raise $150M in public stock offering

By   /  Wednesday, August 3rd, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, Regions, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Arcutis to raise $150M in public stock offering

Arcutis Biotherapeutics, a Westlake Village-based company developing drugs for immune dermatological conditions, plans to raise $150 million through a public offering of additional shares of common stock. Arcutis announced the pricing of those shares on Aug. 2, at $20 per share. Shares of Arcutis closed at $19.50 that day and then shot up 17% on Read More →

Latest

Arcutis reports Q1 loss, progress toward product launch

By   /  Wednesday, May 11th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Tri-County Public Companies, Ventura County  /  Comments Off on Arcutis reports Q1 loss, progress toward product launch

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Arcutis share up after earnings report; company reports mounting losses but progress toward FDA approval

By   /  Monday, February 28th, 2022  /  Banking & Finance, Earnings, East Ventura County, Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Arcutis share up after earnings report; company reports mounting losses but progress toward FDA approval

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Tech Briefcase: Interlink expands in Scotland; Arcutis gets patent; Marcus & Millichap hacked

By   /  Friday, October 1st, 2021  /  Banking & Finance, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Tech Briefcase: Interlink expands in Scotland; Arcutis gets patent; Marcus & Millichap hacked

Interlink Electronics, an Irvine-based sensor manufacturer with its research and development hub in Camarillo, announced Sept. 23 that it plans to expand its European presence with a new engineering team in Scotland. The new team will start with five engineers and will be located near the University of Strathclyde in Glasgow. To support the group, Read More →

Latest

Arcutis ends phase 2 trials on potential skin treatment

By   /  Thursday, July 1st, 2021  /  Banking & Finance, East Ventura County, Health Care & Life Science, Latest news, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Arcutis ends phase 2 trials on potential skin treatment

Shares of Westlake Village-based Arcutis Biotherapeutics dropped by as much as 5% during the trading day July 1, after the biotech company terminated phase 2 trials for a potential treatment. Arcutis, a biotech company focused on creating dermatology treatments, has announced July that it had terminated phase 2a and 2b trials for evaluating ARQ-252, a Read More →

Latest

Arcutis shares down after earnings report

By   /  Tuesday, May 4th, 2021  /  Banking & Finance, Earnings, East Ventura County, Health Care & Life Science, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Arcutis shares down after earnings report

Westlake Village-based Arcutis Biotherapeutics suffered a net loss in the first quarter of fiscal year 2021, but continues to hold a strong financial position with $446.5 million in assets. According to earnings released May 4, Arcutis lost $36 million in the first quarter, or 76 cents per share, compared to a loss of $28 million, Read More →